CERIDIAN HCM Revenue, Profits - CDAY Quarterly Income Statement

Add to My Stocks
$34.53 $0.14 (0.41%) CDAY stock closing price Aug 14, 2018 (Closing)
Fiscal year is Jan - Dec2018 Q22018 Q1
CERIDIAN HCM Revenues or Net Sales
Cost Of Goods Sold (COGS)106.5M119.7M
Research & Development Expense--
Selling General & Admin Expense84.1M62.8M
Income Before Depreciation Depletion Amortization-11.3M26.4M
Depreciation Depletion Amortization--
Non Operating Income--
Interest Expense43.4M22.2M
CERIDIAN HCM Pretax Income
Provision for Income Taxes1.1M6.8M
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations-55.8M-2.6M
Extraordinary Items & Discontinued Operations-9.7M-
CERIDIAN HCM Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS113.31M65.32M
Average Shares used to compute Basic EPS113.31M65.32M
Income Before Nonrecurring Items-15.51M-2.1M
Income from Nonrecurring Items-40.29M-
CERIDIAN HCM Earnings Per Share Basic Net
CERIDIAN HCM Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.15-0.11
Preferred Dividends Acc Pd-5.08M
Dividends Common0.00-
Dividend Per Share Common0.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

CERIDIAN HCM Income Statement - Key Financial Ratios

Dividend Yield